Efficacy of ethyl-eicosapentaenoic acid in bipolar depression: randomised double-blind placebo-controlled study - PubMed
Randomized Controlled Trial
doi: 10.1192/bjp.188.1.46.
Affiliations
- PMID: 16388069
- DOI: 10.1192/bjp.188.1.46
Randomized Controlled Trial
Efficacy of ethyl-eicosapentaenoic acid in bipolar depression: randomised double-blind placebo-controlled study
Sophia Frangou et al. Br J Psychiatry. 2006 Jan.
Abstract
Background: Epidemiological and clinical studies suggest that increased intake of eicosapentaenoic acid (EPA) alleviates unipolar depression.
Aims: To examine the efficacy of EPA in treating depression in bipolar disorder.
Method: In a12-week, double-blind study individuals with bipolar depression were randomly assigned to adjunctive treatment with placebo (n=26) or with 1 g/day (n=24) or 2 g/day (n=25) of ethyl-EPA. Primary efficacy was assessed by the Hamilton Rating Scale for Depression (HRSD), with changes in the Young Mania Rating Scale and Clinical Global Impression Scale (CGI) as secondary outcome measures.
Results: There was no apparent benefit of 2 g over 1 g ethyl-EPA daily. Significant improvement was noted with ethyl-EPA treatment compared with placebo in the HRSD (P=0.04) and the CGI (P=0.004) scores. Both doses were well tolerated.
Conclusions: Adjunctive ethyl-EPA is an effective and well-tolerated intervention in bipolar depression.
Comment in
-
Ethyl-eicosapentaenoic acid in bipolar depression.
Upton I. Upton I. Br J Psychiatry. 2006 Aug;189:191. doi: 10.1192/bjp.189.2.191. Br J Psychiatry. 2006. PMID: 16880499 No abstract available.
Similar articles
-
Keck PE Jr, Mintz J, McElroy SL, Freeman MP, Suppes T, Frye MA, Altshuler LL, Kupka R, Nolen WA, Leverich GS, Denicoff KD, Grunze H, Duan N, Post RM. Keck PE Jr, et al. Biol Psychiatry. 2006 Nov 1;60(9):1020-2. doi: 10.1016/j.biopsych.2006.03.056. Epub 2006 Jun 30. Biol Psychiatry. 2006. PMID: 16814257 Clinical Trial.
-
Keck PE Jr, Versiani M, Potkin S, West SA, Giller E, Ice K; Ziprasidone in Mania Study Group. Keck PE Jr, et al. Am J Psychiatry. 2003 Apr;160(4):741-8. doi: 10.1176/appi.ajp.160.4.741. Am J Psychiatry. 2003. PMID: 12668364 Clinical Trial.
-
Calabrese JR, Keck PE Jr, Macfadden W, Minkwitz M, Ketter TA, Weisler RH, Cutler AJ, McCoy R, Wilson E, Mullen J. Calabrese JR, et al. Am J Psychiatry. 2005 Jul;162(7):1351-60. doi: 10.1176/appi.ajp.162.7.1351. Am J Psychiatry. 2005. PMID: 15994719 Clinical Trial.
-
Houston JP, Tohen M, Degenhardt EK, Jamal HH, Liu LL, Ketter TA. Houston JP, et al. J Clin Psychiatry. 2009 Nov;70(11):1540-7. doi: 10.4088/JCP.08m04895yel. Epub 2009 Sep 22. J Clin Psychiatry. 2009. PMID: 19778495 Clinical Trial.
-
Ethyl-EPA in Huntington disease: potentially relevant mechanism of action.
Murck H, Manku M. Murck H, et al. Brain Res Bull. 2007 Apr 30;72(2-3):159-64. doi: 10.1016/j.brainresbull.2006.10.020. Epub 2006 Nov 15. Brain Res Bull. 2007. PMID: 17352940 Review.
Cited by
-
The Black Book of Psychotropic Dosing and Monitoring.
Schatzberg AF, Charles D. Schatzberg AF, et al. Psychopharmacol Bull. 2018 Jan 15;48(1):64-153. Psychopharmacol Bull. 2018. PMID: 29382960 Free PMC article. Review. No abstract available.
-
Igarashi M, Chang L, Ma K, Rapoport SI. Igarashi M, et al. Prostaglandins Leukot Essent Fatty Acids. 2013 Nov-Dec;89(6):403-12. doi: 10.1016/j.plefa.2013.09.004. Epub 2013 Sep 16. Prostaglandins Leukot Essent Fatty Acids. 2013. PMID: 24209500 Free PMC article.
-
N-3 Polyunsaturated Fatty Acids through the Lifespan: Implication for Psychopathology.
Pusceddu MM, Kelly P, Stanton C, Cryan JF, Dinan TG. Pusceddu MM, et al. Int J Neuropsychopharmacol. 2016 Dec 30;19(12):pyw078. doi: 10.1093/ijnp/pyw078. Print 2016 Dec. Int J Neuropsychopharmacol. 2016. PMID: 27608809 Free PMC article. Review.
-
Omega-3 fatty acids for depression in adults.
Appleton KM, Voyias PD, Sallis HM, Dawson S, Ness AR, Churchill R, Perry R. Appleton KM, et al. Cochrane Database Syst Rev. 2021 Nov 24;11(11):CD004692. doi: 10.1002/14651858.CD004692.pub5. Cochrane Database Syst Rev. 2021. PMID: 34817851 Free PMC article. Review.
-
Spanemberg L, Massuda R, Lovato L, Paim L, Vares EA, Sica da Rocha N, Ceresér KM. Spanemberg L, et al. Psychiatr Q. 2012 Jun;83(2):161-75. doi: 10.1007/s11126-011-9191-1. Psychiatr Q. 2012. PMID: 21927937 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials